The second type is secondary plasma cell leukemia, which is cancer that happens when multiple myeloma transforms and spreads to the blood. Because modern treatment is prolonging the lives of ...

Plasma cell leukemia (PCL) is a rare disease that may ... lenalidomide and transplant-based regimens will probably improve treatment outcome. There is insufficient information to support ...

Literature about PPCL treatment is limited, sometimes conflicting, and often based on case reports or small retrospective series that frequently include both younger and elderly patients or secondary ...

In addition, the researchers discovered that plasma cells secreting anti-CD19 bispecific antibodies elicited antitumor activity, as demonstrated with acute lymphoblastic leukemia patient-derived ...

Cancer is an umbrella term for abnormal excess growth that can occur in any part of the body. Leukemia is the cancer of blood, which means there is rapid growth of abnormal blood cells. This ...

Steroids enhance the efficacy of my cancer chemo treatment, but its long term ... years in cancer remission of multiple myeloma/plasma cell leukemia. He has been sober for 32 years.

The plasma cells multiply and release damaging substances ... but may suddenly transform into a severe leukemia. Treatments may include blood transfusions, chemotherapy and stem cell transplant.

Researchers show for the first time that engineered human plasma B cells ... leukemia (B-ALL). Blinatumomab is a bispecific antibody that received FDA approval in 2014 for the treatment of ...

What do leukemia ... red blood cells, white blood cells, and platelets. Myeloma (also called multiple myeloma) is a cancer that develops in a type of white blood cell called a plasma cell.